11 rezultatima
This application is a national phase application under 35 U.S.C. .sctn.371 of International Application Serial No. PCT/KR2013/010108 filed on Nov. 8, 2013, and claims the priority under 35 U.S.C. .sctn.119 to Korean Patent Application No. 10-2013-0111392, filed on Sep. 16, 2013, which are hereby
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to methods of obtaining lignan from plant materials, particularly flax and flaxseed. The invention is also directed to compositions containing lignan obtained from the methods described herein.
2. Background
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to new pharmaceutical compositions containing lignans for use in therapy. The present invention also relates to pharmaceutical combinations of lignans and TRAIL receptor agonists. In particular, the present invention
FIELD OF INVENTION
This invention is directed to methods and compositions for treating pathological lung conditions using whole-grain flaxseed or flaxseed lignans (isolated in form of the lignan precursor Secoisolariciresinol diglucoside (SDG) directly from whole-grain flaxseed or chemically
This invention relates to compositions extracted from vegetable matter and more particularly to phytochemicals, including saponogenins and saponins, catechins, lignans, phenolic acids, and isoflavones, and especially those extracted from a family of plants including soy, flax, tea, and cocoa, and
This invention relates to compositions extracted from vegetable matter and more particularly to phytochemicals, including saponogenins and saponins, lignans, phenolic acids, catechins and isoflavones, and especially those extracted from a family of plants including soy, flax, tea, and cocoa and
FIELD OF INVENTION
The present invention relates to a novel herbal composition for the treatment of cancer. The present invention particularly relates to an herbal formulation comprising mixture of lignans isolated from the plant Cedrus Deodara.
BACKGROUND OF INVENTION
Cancer or neoplasm is the
FIELD OF INVENTION
The present invention relates to a novel herbal composition for the treatment of cancer. The present invention particularly relates to an herbal formulation comprising mixture of lignans isolated from the plant Cedrus Deodara.
BACKGROUND OF INVENTION
Cancer or neoplasm is the
BACKGROUND OF THE INVENTION
The present invention relates to a pharmaceutical composition comprising specific compounds which may be obtained from Leontopodium alpinum Cass. (Edelweiss), or structurally related compounds. A preferred compound is leoligin
The present invention relates to a pharmaceutical composition comprising specific compounds which may be obtained from Leontopodium alpinum Cass. (Edelweiss), or structurally related compounds. A preferred compound is leoligin (=(2S,3R,4R)-4-(3,4-dimethoxybenzyl)-2-(3,4-dimethoxyphenyl)tetr-
This invention relates to compositions extracted from vegetable matter and more particularly to phytochemicals, including saponogenins and saponins, lignans, phenolic acids, catechins and isoflavones, and especially those extracted from a family of plants including soy, flax, tea, and cocoa and